CIK: 0001595851 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: Apr 9, 2020
Total Value: $383M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A S | 385,000 | $45.31M | 11.8% | $95.44 | — | SPONSORED ADR | 04351P101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 900,000 | $24.16M | 6.3% | $23.61 | -1.1% | COM | 004225108 |
| ASND | ASCENDIS PHARMA A S | 185,000 | $21.77M | 5.7% | $95.44 | — | Put | 04351P101 |
| — | BLUEPRINT MEDICINES CORP | 240,000 | $19.21M | 5.0% | $80.05 | — | COM | 09627Y109 |
| FOLD | AMICUS THERAPEUTICS INC | 1,300,000 | $17.68M | 4.6% | $11.60 | +5.3% | COM | 03152W109 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 300,000 | $15.88M | 4.1% | $49.14 | — | COM | 37890U108 |
| — | IMMUNOMEDICS INC | 800,000 | $15.37M | 4.0% | $8.35 | — | COM | 452907108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 80,000 | $14.72M | 3.8% | $173.27 | +6.6% | COM | 92532F100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 150,000 | $14.02M | 3.7% | $87.26 | -4.2% | COM | 02043Q107 |
| — | SAGE THERAPEUTICS INC | 75,000 | $11.93M | 3.1% | $158.27 | — | COM | 78667J108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 400,000 | $11.45M | 3.0% | $16.62 | +30.5% | COM | 483497103 |
| — | RETROPHIN INC | 500,000 | $11.31M | 3.0% | $26.90 | — | COM | 761299106 |
| — | MIRATI THERAPEUTICS INC | 150,000 | $10.99M | 2.9% | $33.00 | — | COM | 60468T105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,150,000 | $10.94M | 2.9% | $9.65 | +0.6% | COM | 462260100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 600,000 | $10.52M | 2.7% | $16.85 | -6.3% | COM | 77313F106 |
| — | CYMABAY THERAPEUTICS INC | 750,000 | $9.96M | 2.6% | $13.28 | — | COM | 23257D103 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 175,000 | $9.007M | 2.4% | $37.40 | — | Call | G11196105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 700,000 | $8.799M | 2.3% | $8.83 | 0.0% | COM | 74366E102 |
| FXF | INVESCO CURNCYSHS SWISS FRAN | 91,800 | $8.574M | 2.2% | $94.55 | — | SWISS FRANC | 46138R108 |
| ANAB | ANAPTYSBIO INC | 115,000 | $8.401M | 2.2% | $80.01 | -13.7% | COM | 032724106 |
| — | MOMENTA PHARMACEUTICALS INC | 500,000 | $7.265M | 1.9% | $12.26 | — | COM | 60877T100 |
| — | AUDENTES THERAPEUTICS INC | 175,000 | $6.829M | 1.8% | $21.32 | — | COM | 05070R104 |
| — | RA PHARMACEUTICALS INC | 300,000 | $6.72M | 1.8% | $22.40 | — | COM | 74933V108 |
| — | DBV TECHNOLOGIES S A | 850,000 | $6.554M | 1.7% | $7.71 | — | SPONSORED ADR | 23306J101 |
| — | EPIZYME INC | 500,000 | $6.195M | 1.6% | $12.39 | — | COM | 29428V104 |
| CHRS | COHERUS BIOSCIENCES INC | 450,000 | $6.138M | 1.6% | $13.34 | 0.0% | COM | 19249H103 |
| — | TRICIDA INC | 150,000 | $5.793M | 1.5% | $30.07 | — | COM | 89610F101 |
| — | KADMON HLDGS INC | 2,100,000 | $5.544M | 1.4% | $3.79 | — | COM | 48283N106 |
| VRAYQ | VIEWRAY INC | 750,000 | $5.543M | 1.4% | $6.99 | +10.4% | COM | 92672L107 |
| — | ORCHARD THERAPEUTICS PLC | 300,000 | $5.364M | 1.4% | $15.73 | — | ADS | 68570P101 |
| AXSM | AXSOME THERAPEUTICS INC | 310,000 | $4.411M | 1.2% | $9.29 | 0.0% | COM | 05464T104 |
| BCRX | BIOCRYST PHARMACEUTICALS | 500,000 | $4.07M | 1.1% | $6.72 | +27.5% | COM | 09058V103 |
| — | CHIASMA INC | 700,000 | $3.64M | 1.0% | $5.20 | — | COM | 16706W102 |
| ARVN | ARVINAS INC | 175,000 | $2.583M | 0.7% | $16.46 | +7.8% | COM | 04335A105 |
| — | OBSEVA SA | 200,000 | $2.558M | 0.7% | $11.87 | — | COM | H5861P103 |
| — | GENOCEA BIOSCIENCES INC | 2,000,000 | $1.18M | 0.3% | $0.86 | — | COM | 372427104 |
| — | SOLID BIOSCIENCES INC | 100,000 | $920K | 0.2% | $9.20 | — | COM | 83422E105 |
| — | CATALYST BIOSCIENCES INC | 100,000 | $811K | 0.2% | $25.80 | — | COM NEW | 14888D208 |
| — | FIBROGEN INC | 11,500 | $625K | 0.2% | $54.35 | — | COM | 31572Q808 |